We're standing by & we can help. It's free and confidential.*
Or Call Us Now: (800) 476-6070*I agree that submitting this form does not create an attorney client relationship and that Weitz & Luxenberg will use the information I am providing to check for conflicts of interest to determine if the firm can assist me.
Get in touch
Telephone: (212) 558-5500
Fax: (212) 344-5461
New York, NY 10003
For two decades, Mr. Pennock has been chair of the Drug and Medical Device Litigation practice group at Weitz & Luxenberg.
He is directly responsible for leading a large national litigation department covering all aspects of litigation — from inception through trial. He has served as lead plaintiffs’ counsel, as well as plaintiff steering committee member, and liaison counsel in numerous state and federal multidistrict-litigation (MDL) mass tort cases.
This includes his current appointment as co-lead of the federal court Actos Multidistrict-Litigation coordination. In this role, he led the efforts in the recent $9 billion jury verdict, at the time the highest jury verdict in history for a personal injury case. Mr. Pennock has also handled numerous bellwether trials and Daubert hearings on expert-witness testimony in both state and federal courts.
As a well-respected member of the bar, he has been an invited speaker to dozens of legal conferences around the country, as well as at several law schools including Yale, Brooklyn, and the University of Denver, among others.
In 2007, he was honored with the invitation to author the mass tort litigation chapter in a two-volume legal treatise, "The Plaintiff’s Personal Injury Action in New York State" published by New York State Bar Association, edited by Patrick J. Higgins. It was published in 2009 and Mr. Pennock regularly provides updates.
He has been selected to Best Lawyers and Super Lawyers for 10 years running and the National Law Journal calls him one of "America's Elite Trial Lawyers."
Mr. Pennock is widely considered, by both sides of the bar, as one of the best and most aggressive plaintiff litigators in the country. His work has led to more than a billion dollars in recoveries for Weitz & Luxenberg clients.
W&L's Ellen Relkin, as lead counsel in the NJ Rejuvenate and ABG II hip stem litigation, played a key role in negotiating the more than $1 billion settlement. Most qualifying plaintiffs will receive $300,000 or more.
W&L helped negotiate one of the largest mass tort settlements in recent history. More than 300 W&L clients are part of the settlement. Claimants had recalled DePuy ASR hips implanted and removed prior to August 31, 2013.